Ernexa Therapeutics (ERNAW) FCF Margin Growth (3y) (2013 - 2023)
Ernexa Therapeutics (ERNAW) FCF Margin Growth (3y) (2013 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ernexa Therapeutics |
- |
- |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
-940,832.00 |
| Sep 30, 2023 |
-1.13 Mn |
| Dec 31, 2020 |
-13,479.00 |
| Sep 30, 2020 |
-12,377.00 |
| Mar 31, 2020 |
-6,661.00 |
| Dec 31, 2019 |
1,573.00 |
| Sep 30, 2019 |
784.00 |
| Jun 30, 2019 |
-289.00 |
| Mar 31, 2019 |
2,258.00 |
| Dec 31, 2018 |
3,063.00 |
| Sep 30, 2018 |
3,799.00 |
| Jun 30, 2018 |
4,298.00 |
| Mar 31, 2018 |
-1,911.00 |
| Dec 31, 2017 |
6,610.00 |
| Sep 30, 2017 |
-169.00 |
| Jun 30, 2017 |
9,236.00 |
| Mar 31, 2017 |
496.00 |
| Dec 31, 2016 |
1,458.00 |
| Sep 30, 2016 |
-2,963.00 |
| Jun 30, 2016 |
1,273.00 |
